Craneware (LON:CRW)‘s stock had its “buy” rating reiterated by stock analysts at Peel Hunt in a note issued to investors on Wednesday, January 3rd. They currently have a GBX 1,800 ($24.41) target price on the stock. Peel Hunt’s target price would suggest a potential upside of 4.96% from the company’s previous close.
Separately, N+1 Singer restated a “hold” rating on shares of Craneware in a report on Tuesday, September 5th.
Shares of Craneware (LON CRW) opened at GBX 1,715 ($23.26) on Wednesday. The company has a market capitalization of $512.67 and a price-to-earnings ratio of 4,763.89. Craneware has a 1-year low of GBX 1,165 ($15.80) and a 1-year high of GBX 1,885 ($25.56).
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with our FREE daily email newsletter.